US regulator alleges Dr Reddy's breached packaging rules

Tags: Companies
Export-focused drugmaker Dr Reddy's Laboratories Ltd said it was in talks with a US regulator over allegations it violated packaging rules for some prescription drugs sold there between 2008 and 2012.

The allegations by the U.S. government's Consumer Product Safety Commission (CPSC) are the latest in a series of regulatory troubles facing Indian pharmaceutical firms in their biggest export market, the United States.

In a U.S. stock exchange filing this week, Dr Reddy's said the CPSC planned to seek civil penalties against the company for allegedly violating rules intended to prevent children from ingesting harmful substances.

The company said any unfavourable outcome could result in "significant liabilities" and added that it disagreed with the allegations.

Indian drugmakers have suffered a string of drug recalls and manufacturing quality-related issues that have hurt the reputation of the $15 billion-a-year industry as a supplier of cheap generic drugs, and led to increased scrutiny from regulators.

EDITORIAL OF THE DAY

  • Fall in sale of e-books globally is being attributed to screen fatigue

    Screen fatigue seems to have hit the human race big time, given that eyes are constantly exposed to various screens, from android and Apple I-phones,

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Disequilibrium: INDIA’S kill zones

In a curious twist after the 1999 Lok Sabha hustings, ...

Gautam Datt

<b>Newsmaker<b>: Caught in the middle

Historic opportunities can be easily squandered if they are not ...

Kuruvilla Pandikattu

The forgotten hero of science & religion

Young students of science will recognise Albert Einstein, Isaac Newton, ...